Court Denies Illumina Appeal to Reconsider Ruling in Patent Suit Against Complete Genomics | GenomeWeb

NEW YORK (GenomeWeb News) – In a patent infringement suit between Illumina and Complete Genomics, the US District Court for the Northern District of California this week denied a motion by Illumina to reconsider a judgment the court rendered in favor of Complete Genomics last October.

The October ruling found certain claims of an Illumina patent to be invalid due to prior art.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.